实用肝脏病杂志
實用肝髒病雜誌
실용간장병잡지
JOURNAL OF CLINICAL HEPATOLOGY
2014年
2期
168-171
,共4页
急性肝损伤%伴刀豆球蛋白A%KM小鼠%BABL/c小鼠%C57BL/6J小鼠
急性肝損傷%伴刀豆毬蛋白A%KM小鼠%BABL/c小鼠%C57BL/6J小鼠
급성간손상%반도두구단백A%KM소서%BABL/c소서%C57BL/6J소서
Acute liver injury%Concanavalin A%KM mice%BABL/c mice%C57BL/6J mice
目的:应用不同剂量伴刀豆球蛋白 A(ConA)诱导三种不同品系小鼠急性肝损伤,比较肝酶变化、死亡率和肝组织病理学变化。方法分别用6、12、20和30 mg·kg-1 ConA 处理 C57BL/6J、BABL/c 和 KM 小鼠,8 h 后对比观察急性肝损伤动物血清酶学及肝组织病理学变化情况。结果在6 mg·kg-1 ConA 的作用下,三个品系小鼠均被成功制造出急性肝损伤模型;在12 mg·kg-1 ConA 作用下,KM 小鼠血清 ALT 和AST 分别为(1006.8±12.1) U/L 和(1391.8±13.4)U/L,显著高于 BABL/c 小鼠[(75.7±0.5)U/L 和(284.7±23.4) U/L)和 C57BL/6J 小鼠(104.4±32.2)U/L 和(492.2±12.3)U/L,P 均<0.05];同样,KM 小鼠肝指数和脾指数分别为(5.4±0.3)和(0.7±0.5),均显著高于 BABL/c 小鼠[(5.2±0.4)和(0.6±0.3)和 C57BL/6J 小鼠(5.0±0.6)和(0.6±0.2),P 均<0.05];在20 mg·kg-1 ConA 作用下,三组小鼠血清 AST 和 ALT 水平无统计学差异,但 BABL/c 小鼠(4/10)和 C57BL/6J 小鼠(5/10)死亡率显著高于 KM 小鼠(1/10);在30 mg·kg-1 ConA 作用下,三个品系小鼠死亡率均较高(KM 小鼠为30%,BABL/c 和C57BL/6J 小鼠均为100%)。结论不同品系的小鼠对 ConA 的耐受性不同,KM 小鼠对 ConA 的耐受性明显优于BABL/c 小鼠和 C57BL/6J 小鼠,且呈剂量依赖性。
目的:應用不同劑量伴刀豆毬蛋白 A(ConA)誘導三種不同品繫小鼠急性肝損傷,比較肝酶變化、死亡率和肝組織病理學變化。方法分彆用6、12、20和30 mg·kg-1 ConA 處理 C57BL/6J、BABL/c 和 KM 小鼠,8 h 後對比觀察急性肝損傷動物血清酶學及肝組織病理學變化情況。結果在6 mg·kg-1 ConA 的作用下,三箇品繫小鼠均被成功製造齣急性肝損傷模型;在12 mg·kg-1 ConA 作用下,KM 小鼠血清 ALT 和AST 分彆為(1006.8±12.1) U/L 和(1391.8±13.4)U/L,顯著高于 BABL/c 小鼠[(75.7±0.5)U/L 和(284.7±23.4) U/L)和 C57BL/6J 小鼠(104.4±32.2)U/L 和(492.2±12.3)U/L,P 均<0.05];同樣,KM 小鼠肝指數和脾指數分彆為(5.4±0.3)和(0.7±0.5),均顯著高于 BABL/c 小鼠[(5.2±0.4)和(0.6±0.3)和 C57BL/6J 小鼠(5.0±0.6)和(0.6±0.2),P 均<0.05];在20 mg·kg-1 ConA 作用下,三組小鼠血清 AST 和 ALT 水平無統計學差異,但 BABL/c 小鼠(4/10)和 C57BL/6J 小鼠(5/10)死亡率顯著高于 KM 小鼠(1/10);在30 mg·kg-1 ConA 作用下,三箇品繫小鼠死亡率均較高(KM 小鼠為30%,BABL/c 和C57BL/6J 小鼠均為100%)。結論不同品繫的小鼠對 ConA 的耐受性不同,KM 小鼠對 ConA 的耐受性明顯優于BABL/c 小鼠和 C57BL/6J 小鼠,且呈劑量依賴性。
목적:응용불동제량반도두구단백 A(ConA)유도삼충불동품계소서급성간손상,비교간매변화、사망솔화간조직병이학변화。방법분별용6、12、20화30 mg·kg-1 ConA 처리 C57BL/6J、BABL/c 화 KM 소서,8 h 후대비관찰급성간손상동물혈청매학급간조직병이학변화정황。결과재6 mg·kg-1 ConA 적작용하,삼개품계소서균피성공제조출급성간손상모형;재12 mg·kg-1 ConA 작용하,KM 소서혈청 ALT 화AST 분별위(1006.8±12.1) U/L 화(1391.8±13.4)U/L,현저고우 BABL/c 소서[(75.7±0.5)U/L 화(284.7±23.4) U/L)화 C57BL/6J 소서(104.4±32.2)U/L 화(492.2±12.3)U/L,P 균<0.05];동양,KM 소서간지수화비지수분별위(5.4±0.3)화(0.7±0.5),균현저고우 BABL/c 소서[(5.2±0.4)화(0.6±0.3)화 C57BL/6J 소서(5.0±0.6)화(0.6±0.2),P 균<0.05];재20 mg·kg-1 ConA 작용하,삼조소서혈청 AST 화 ALT 수평무통계학차이,단 BABL/c 소서(4/10)화 C57BL/6J 소서(5/10)사망솔현저고우 KM 소서(1/10);재30 mg·kg-1 ConA 작용하,삼개품계소서사망솔균교고(KM 소서위30%,BABL/c 화C57BL/6J 소서균위100%)。결론불동품계적소서대 ConA 적내수성불동,KM 소서대 ConA 적내수성명현우우BABL/c 소서화 C57BL/6J 소서,차정제량의뢰성。
Objective To compare the differences in serum liver enzymes, mortality and liver histological changes in three different strains of mice with concanavalin A (ConA) -induced acute hepatic injury (AHI). Methods C57BL/6J mice,BABL/c mice and KM mice were subjected to ConA at four different dosages (i.e.6, 12,20 and 30 mg·kg-1) for 8 hours,and then mice were sacrificed and serum liver enzymes and liver histological changes were examined. Results ConA at dose of 6 mg·kg-1 successfully induced acute liver injury in all three strains of mice;ConA at dose of 12 mg·kg-1 caused remarkable increases in serum ALT (1006.8 ± 12.1) U/L and AST (1391.8 ± 13.4)U/L levels in KM mice,significantly higher than those in BABL/c mice [(75.7 ± 0.5) U/L and(284.7 ± 23.4) U/L,respectively and in C57BL/6J mice (104. ±32.2) U/L and (492.2 ± 12.3) U/L,re-spectively,P<0.05];Similarly,liver index(5.4±0.3) and spleen index(0.7±0.5) in KM mice were significantly high-er than that in BABL/c mice [(5.2±0.4) and (0.6±0.3),respectively and in C57BL/6J mice(5.0±0.6) and (0.6±0. 2),respectively,P<0.05];Serum ALT and AST levels did not differ among three strains of mice when Con A at dose of 20 mg·kg -1 was used,however,the mortality in BABL/c (4/10) and C57BL/6J (5/10) was significantly higher than that in KM mice (1/10);30 mg·kg -1 of ConA resulted in a remarkably high mortality in all three strains of mice (30% in KM mice,100% in BABL/c and 100% in C57BL/6J mice). Conclusion Mouse strains play a significant role in liver response to Con A,and the tolerance of KM mice to ConA is better than BABL/c and C57BL/6J mice and the liver damage is in a dose-dependent manner.